本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Aquestive Therapeutics Inc.

3.00
+0.07502.56%
盤後3.000.00000.00%16:13 EDT
成交量:121.50萬
成交額:359.58萬
市值:2.97億
市盈率:-5.89
高:3.04
開:2.94
低:2.84
收:2.93
資料載入中...

公司資料

公司名字:
Aquestive Therapeutics Inc.
交易所:
NASDAQ
成立時間:
2004
員工人數:
142
公司地址:
30 Technology Drive,Warren,New Jersey,United States
郵編:
07059
電話:
傳真:
- -
簡介:
Aquestive Therapeutics, Inc.於2004年1月在特拉華州成立。Aquestive是一家推進藥物的製藥公司,通過創新的科學和遞送技術為患者的生活帶來有意義的改善。該公司正在開發醫藥產品,通過替代侵入性和不方便的標準護理療法的給藥來遞送複雜的分子。Aquestive還與製藥公司合作,利用PharmFilm等專有、同類最佳技術將新分子推向市場,並已證明具有藥物開發和商業化能力。該公司還開發了專註於治療中樞神經系統疾病的產品管線。

董事

名稱
職位
John Cochran
Vice Chairman of the Board
Keith J. Kendall
Chief Executive Officer, President and Director
Santo Costa
Chairman of the Board
James S. Scibetta
Director
Julie Krop
Director
Marco Taglietti
Director
Nancy Lurker
Director

股東

名稱
職位
Keith J. Kendall
Chief Executive Officer, President and Director
Daniel Barber
Senior Vice President - Chief Operating Officer
A. Ernest Toth, Jr.
Interim Chief Financial Officer
Gary H. Slatko
Senior Vice President - Chief Medical Officer
Ken Marshall
Senior Vice President - Chief Commercial Officer
Lori J. Braender
Senior Vice President - General Counsel, Chief Compliance Officer and Corporate Secretary
Peter Boyd
Senior Vice President - Business Process and Information Technology
Theresa Wood
Senior Vice President - Human Resources and Organizational Development
A. Mark Schobel
Chief Innovation and Technology Officer